Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
about
Crystal structure elucidation and anticancer studies of (-)-pseudosemiglabrin: a flavanone isolated from the aerial parts of Tephrosia apollineaEarly spatial and temporal changes in tumour perfusion after administration of flavone acetic acid.Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy.Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studiesDifferential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft.Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenograftsUnique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunities.Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours.Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.Flavone acetic acid induces a coagulopathy in mice.Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.Divergent effects of flavone acetic acid on established versus developing tumour blood flow.Flavone acetic acid: is vascular shutdown the crucial mechanism of action.Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites.Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.Effect of ethyl acetate aroma on viability of human breast cancer and normal kidney epithelial cells in vitro.
P2860
Q21132294-0B46B810-10EC-4317-AA7D-33948745CF56Q30817970-FE8ED430-602F-41BA-A08A-68BA5555DDD6Q30835449-C3A0D0D7-8FDE-491C-A677-25FA4BA4EF8AQ35977045-39D2D2ED-B674-4C76-9707-1BD17329F6D8Q35982503-31DFB920-4321-4B13-8F3F-7C579995C2E5Q36466092-E4163271-998A-4643-9BFF-B8CFAE0F8D27Q36466293-557DBC8D-6080-4F30-A239-E87FE4101EA3Q36466570-A9E8678C-6DAC-4F84-857F-0A6873DB0D19Q37668618-5AA66DEA-F5C7-43D8-874A-756C73D930E5Q38671961-0167D014-EFD0-45BB-9B82-0DCE2F7A93ABQ40486205-1FCD4BB2-522F-4BEB-8B8D-2BA149CE0047Q41329105-502CE4BE-49AD-4738-8645-8AFB6D2DFF04Q41337809-494406F1-EDA7-42C2-9AD6-3995B194B8CFQ41808425-8529A0EA-72EE-4983-99C2-47303223E086Q41910308-24B347A1-0951-4687-B39C-20EE3607281DQ41914895-997CA1CB-216D-4A8F-AB2A-DB3FD41A680BQ42383799-3B7A4861-4388-4AF3-A138-199177C5B973Q42383807-1E2D1D6D-64FC-42E1-AC12-4C87158151E8Q43236564-C75A46CF-8068-49D8-A545-C1B115CAC1FAQ54967418-0C93F691-9E4C-42E7-A875-B7EB888F46A2
P2860
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@ast
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@en
type
label
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@ast
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@en
prefLabel
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@ast
Factors involved in the anti-c ...... d LM975 (flavone acetic acid).
@en
P2860
P356
P1476
Factors involved in the anti-c ...... nd LM975 (flavone acetic acid)
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1987.32
P407
P577
1987-02-01T00:00:00Z